Position in MBX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$798,081
New position
Shares Held
14,458
first reported quarter
Ownership
0.030%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#89
of 171 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sound Capital Solutions LLC holds $22,837,470 across 24 Biotechnology names. MBX ranks #3 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IBRX |
ImmunityBio, Inc.
|
1,120,808 | $9,812,674 | |
| 2 | ORKA |
Oruka Therapeutics, Inc.
|
13,396 | $1,274,897 | |
| 3 | MBX |
MBX Biosciences, Inc.
This page
|
14,458 | $798,081 | |
| 4 | ELVN |
Enliven Therapeutics, Inc.
|
15,003 | $761,402 | |
| 5 | BCAX |
Bicara Therapeutics Inc.
|
23,913 | $709,976 | |
| 6 | KOD |
Kodiak Sciences Inc.
|
17,767 | $692,202 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
2,721 | $666,019 | |
| 8 | BHVN |
Biohaven Ltd.
|
44,524 | $662,517 |
All Filings in MBX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $798,081 | 14,458 | Shares | Other | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||